Trial intelligence / Profile preview

Impact of 68Ga-PSMA-11 PET/CT in Prostate Cancer

NCT04050215Phase 2Completed

Sponsor
UCLA Jonsson Comprehensive Cancer Center
Start
Apr 2018
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 2, open-label, single-arm trial, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Intended and implemented management changes. Started Apr 2018; status: completed.

Beyond the preview

Go deeper on NCT04050215.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04050215.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call